| Proxiemal vs King | 22–23 | 48.89% |
| Proxiemal vs Bryan | 22–19 | 53.66% |
| Proxiemal vs Lee | 18–17 | 51.43% |
| Proxiemal vs Kazuya | 12–17 | 41.38% |
| Proxiemal vs Jin | 16–11 | 59.26% |
| Proxiemal vs Lili | 15–12 | 55.56% |
| Proxiemal vs Steve | 12–14 | 46.15% |
| Proxiemal vs Reina | 8–18 | 30.77% |
| Proxiemal vs Law | 19–6 | 76.00% |
| Proxiemal vs Clive | 12–13 | 48.00% |
| Proxiemal vs Hwoarang | 10–12 | 45.45% |
| Proxiemal vs Yoshimitsu | 12–9 | 57.14% |
| Proxiemal vs Leo | 11–9 | 55.00% |
| Proxiemal vs Asuka | 9–10 | 47.37% |
| Proxiemal vs Heihachi | 8–11 | 42.11% |
| Proxiemal vs Victor | 9–8 | 52.94% |
| Proxiemal vs Lidia | 10–7 | 58.82% |
| Proxiemal vs Lars | 4–10 | 28.57% |
| Proxiemal vs Jun | 12–2 | 85.71% |
| Proxiemal vs Claudio | 8–5 | 61.54% |
| Proxiemal vs Paul | 6–5 | 54.55% |
| Proxiemal vs Xiaoyu | 7–4 | 63.64% |
| Proxiemal vs Feng | 3–7 | 30.00% |
| Proxiemal vs Dragunov | 5–5 | 50.00% |
| Proxiemal vs Devil Jin | 8–1 | 88.89% |
| Proxiemal vs Azucena | 7–2 | 77.78% |
| Proxiemal vs Jack-8 | 3–5 | 37.50% |
| Proxiemal vs Shaheen | 3–5 | 37.50% |
| Proxiemal vs Nina | 2–6 | 25.00% |
| Proxiemal vs Eddy | 2–3 | 40.00% |
| Proxiemal vs Kuma | 4–0 | 100.00% |
| Proxiemal vs Panda | 4–0 | 100.00% |
| Proxiemal vs Alisa | 2–1 | 66.67% |
| Proxiemal vs Zafina | 2–1 | 66.67% |
| Proxiemal vs Raven | 1–1 | 50.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.